Drug Shortage Report for PRADAXA
Report ID | 104069 |
Drug Identification Number | 02312441 |
Brand name | PRADAXA |
Common or Proper name | Pradaxa |
Company Name | BOEHRINGER INGELHEIM (CANADA) LTD LTEE |
Market Status | MARKETED |
Active Ingredient(s) | DABIGATRAN ETEXILATE |
Strength(s) | 110MG |
Dosage form(s) | CAPSULE |
Route of administration | ORAL |
Packaging size | 60's |
ATC code | B01AE |
ATC description | ANTITHROMBOTIC AGENTS |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | |
Actual start date | 2020-01-17 |
Estimated end date | 2020-02-17 |
Actual end date | 2020-02-03 |
Shortage status | Resolved |
Updated date | 2020-02-04 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 5180 SOUTH SERVICE ROAD BURLINGTON, ONTARIO CANADA L7L 5H4 |
Company contact information | 1800 263 2425 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v4 | 2020-02-04 | French | Compare |
v3 | 2020-02-04 | English | Compare |
v2 | 2020-01-22 | French | Compare |
v1 | 2020-01-22 | English | Compare |
Showing 1 to 4 of 4